Drug Profile
SX 4699
Alternative Names: SX-4699Latest Information Update: 05 Jun 2001
Price :
$50
*
At a glance
- Originator Dainippon Pharmaceutical
- Class Anxiolytics; Benzodiazepines
- Mechanism of Action GABA A receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Anxiety disorders
Most Recent Events
- 05 Jun 2001 Discontinued-Preclinical for Anxiety disorders in Japan (Unknown route)
- 15 Mar 2001 Preclinical development for Anxiety disorders in Japan (Unknown route)